Plus, news about Regeneron's Evkeeza and Cure Alzheimer's:
🇪🇺 EU approves Eli Lilly’s Kisunla: The Alzheimer’s drug originally earned a negative CHMP opinion in March but was re-evaluated in June. Lilly
↧